John Stagg

John Stagg is a prominent academic and researcher in the field of tumor immunology, currently serving as Principal Investigator at CHUM - Centre hospitalier de l'Université de Montréal, Full Professor at Université de Montréal, and Senior Scientist at the Institut du cancer de Montréal, all since August 2010. Stagg is actively involved in various organizations, including roles as a member of the Management Board at BioCanRx and participation on scientific advisory boards for multiple companies, such as Coherus BioSciences and Ability Biologics. With a rich background that includes co-founding Surface Oncology Inc. and serving as a scientific advisor to firms like Tarus Therapeutics, Stagg leverages extensive expertise gained through a Ph.D. in Tumor Immunology from McGill University, obtained between 2000 and 2005.